Phenotypic Screening Deconvolution
Phenotypic Screening Deconvolution is a target deconvolution method that identifies the molecular targets of bioactive compounds discovered through phenotypic screening by integrating experimental and computational approaches to link observed cellular phenotypes to specific protein targets or pathways.
12
Publications
548
Citations
56
Authors
22
Institutions
Publications per year
2017–2026
4
Parents
12
BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry
Igor V. Tetko, Ola Engkvist, Uwe Koch et al. · Molecular Informatics · 2016 · 123 citations · Full text
1–5 of 12
56
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 56
22
AstraZeneca (Sweden)
Södertälje, Sweden
2 h-index
3 publications
258 citations
DiscoveRx (United States)
Fremont, United States
2 h-index
6 publications
765 citations

Howard Hughes Medical Institute
Chevy Chase, United States
1 h-index
1 publications
23 citations
Harold C. Simmons Comprehensive Cancer Center
Dallas, United States
1 h-index
1 publications
23 citations
Corning (United States)
Corning, United States
1 h-index
1 publications
38 citations
AbbVie (United States)
North Chicago, United States
1 h-index
6 publications
114 citations
University of Bonn
Bonn, Germany
1 h-index
3 publications
42 citations
Sanofi (United States)
Bridgewater, United States
1 h-index
3 publications
33 citations
1–8 of 22
3 publications · 77 citations
3
h-index
1 publications · 209 citations
2
h-index
1 publications · 14 citations
1
h-index
1 publications · 18 citations
1
h-index
1 publications · 38 citations
1
h-index
1–5